Oxidative Balance, Inflammation Linked to RA Mortality
-
By
-
Andrea Surnit
-
April 20, 2026
-
3 min
By
Andrea Surnit
April 20, 2026
Nearly 40% of registry patients would have been excluded from phase 3 randomized controlled trials, with exclusion criteria distributed unevenly across drug classes.
June 12, 2026
An aging Japanese cohort with rheumatoid arthritis saw increasing use of targeted synthetic therapies as glucocorticoid use declined.
May 29, 2026